Therefore, this study evaluated the prognostic significance of 18F-fluorodeoxyglucose (18F-FDG) PET/CT values to predict different PD-L1 expression levels in patients with stage IV adenocarcinoma lung cancer. This evidence concerns the gene CD274 and lung cancer.